The effects of aldosterone and mineralocorticoid receptor (MR) blockers on presympathetic neurons in the rostral ventrolateral medulla (RVLM) are well studied. To directly investigate whether aldosterone, eplerenone (an MR blocker), FAD286 (an aldosterone synthase inhibitor) and benzamil (an epithelial sodium channel (ENaC) blocker) affect RVLM neurons, we examined changes in the membrane potentials (MPs) of bulbospinal RVLM neurons using the whole-cell patch-clamp technique during superfusion with these drugs to brainstem-spinal cord preparations. Aldosterone superfusion (0.1 lmol/l) depolarized the RVLM neurons. In contrast, eplerenone superfusion (1 lmol/l) hyperpolarized them. To evaluate the existence of aldosterone, FAD286 superfusion (10 lmol/l) was performed, and the RVLM neurons became hyperpolarized during FAD superfusion. These data suggest that MRs exist and that aldosterone is synthesized in the brainstem. Benzamil superfusion (1 lmol/l) hyperpolarized the RVLM neurons. To clarify whether aldosterone, eplerenone, FAD286 and benzamil acted directly on the RVLM neurons, a lowCa 2 þ , high-Mg 2 þ solution was used to block the synaptic input to the RVLM neurons, and the above-mentioned drugs were added during the low-Ca 2 þ superfusion. During the aldosterone superfusion, the RVLM neurons became depolarized, and they became hyperpolarized during eplerenone, FAD286 or benzamil superfusion. Importantly, when aldosterone was superfused after the benzamil solution, the MPs of the RVLM neurons did not depolarize. These results suggest that MRs are present in the RVLM neurons and that aldosterone is synthesized in the RVLM. The RVLM neurons themselves possess ENaCs, and ENaCs are the underlying mechanism by which aldosterone activates RVLM neurons. Hypertension Research (2013) 36, 504-512; doi:10.1038/hr.2012.224; published online 31 January 2013
INTRODUCTION
The actions of aldosterone include vasoconstriction, vascular fibrosis, endothelial dysfunction, and sodium reabsorption and retention. These actions contribute to hypertension. However, recently, many studies have demonstrated the relationship between aldosterone and sympathetic nerve activity. In fact, aldosterone has been shown to cross the blood-brain barrier relatively easily, 1 as clarified using the model developed by Gomez-Sanchez et al. 2 Gomez-Sanchez et al. 2 showed that the intracerebroventricular infusion of antagonists of the mineralocorticoid receptor (MR), at a dose that had no effect systemically, lowered blood pressure. Intracerebroventricular infusion of aldosterone increased blood pressure, 3 and MRs were found in the brain. 4 Furthermore, aldosterone is involved in remodeling after myocardial infarction, and central blockade of aldosterone has been shown to attenuate cardiac remodeling. 5, 6 Recent studies have demonstrated the existence of an aldosterone system in the brain, 4 and an increase in [Na þ ] in cerebrospinal fluid (CSF) has been shown to increase aldosterone biosynthesis. 7 Although the mechanism was unknown, Zhang et al. 3 demonstrated that aldosterone upregulated key elements (angiotensin II type 1 receptor and angiotensin-converting enzyme in the brain reninangiotensin system) and induced oxidative stress in the hypothalamus. They suggested that aldosterone increased sympathetic nerve activity through those mechanisms. In the brainstem, neurons that contain hydroxysteroid dehydrogenase 2 and MRs were present in the nucleus tractus solitarius. 8 In the rostral ventrolateral medulla (RVLM), Zhu et al. 9 and Nakagaki et al. 10 reported that microinjection of aldosterone into the RVLM increased blood pressure.
However, only a few reports have discussed whether aldosterone directly activates bulbospinal RVLM neurons and whether MRs are present in RVLM neurons. Additionally, few reports have examined whether aldosterone is synthesized in the RVLM. Thus, in the present study, we investigated the effect of aldosterone, eplerenone (an MR blocker), FAD286 (an aldosterone synthase inhibitor) and benzamil (an epithelial sodium channel (ENaC) blocker) on bulbospinal RVLM neurons using brainstem-spinal cord preparations that preserved the sympathetic nervous system. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] As a previous report showed that intracerebroventricular infusion of eplerenone lowered blood pressure, 2, 21 we examined the direct effect of eplerenone on RVLM neurons, using a low-Ca 2 þ , high-Mg 2 þ solution to block synaptic input into RVLM neurons. Aldosterone performs its function in the collecting ducts of the kidneys, and ENaCs are known to participate in the process through genomic action. As ENaCs were shown to exist in the choroid plexus, 22 we investigated how quickly aldosterone activated bulbospinal RVLM neurons and whether ENaCs were involved in the response caused by aldosterone.
METHODS

General preparations
Experiments were performed on the brainstem-spinal cord preparations collected from 1-5-day-old Wistar rats, as previously described. [12] [13] [14] [15] [16] [17] [18] [19] [20] The experimental protocols were approved by the Institutional Review Board of National Defense Medical College and were in accordance with the National Guidelines for the Conduct of Animal Experiments. Briefly, the animals received deep ether anesthesia, and the brainstem-spinal cord was isolated at the Th 2 level (Figure 1a) . The brainstem was sectioned between the roots of cranial nerve VI and the lower border of the trapezoid body. The preparation was continuously superfused with a solution containing in the following solutes in mmol l À1 : 124 NaCl, 5.0 KCl, 1.2 KH 2 PO 4 , 2.4 CaCl 2 , 1.3 MgCl 2 , 26 NaHCO 3 and 30 glucose. The preparation was maintained at 25-26 1C (artificial CSF (aCSF)). The pH (7.4) and oxygenation were maintained by bubbling 90% O 2 -5% N 2 -5% CO 2 through the solution. To avoid recording respiratory neuronal activity, we examined phrenic nerve activity from the ventral root of C 4 ( Figure 1a ) and excluded neurons with a strong phase relationship with the phrenic nerve discharge from further study. 12, 16, 17 Patch-clamp electrodes Electrodes were pulled in one stage from thin-wall borosilicate filament capillaries (GC100TF-10, outer diameter 1.0 mm, Clark Electromed, Reading, UK) using a vertical puller. The electrodes had a tip diameter of 1.8-2.0 mm and a resistance of 4-6 MO. The electrode solution for the whole-cell recording consisted of the following in mmol/l: 130 potassium gluconate, 10 HEPES, 10 EGTA, 1 CaCl 2 and 1 MgCl 2 , with pH 7.2-7.3 adjusted using KOH. The electrode tips were filled with 1% Lucifer-Yellow (Sigma, St Louis, MO, USA).
Recording procedure
Electrodes were inserted into the RVLM. A patch-clamp amplifier (AxoPatch, ID; Axon Instruments, Sunnyvale, CA, USA) was used to record the membrane potentials (MPs). The RVLM neurons were found on the ventral side of the medulla. Before making the intracellular whole-cell recordings, we observed the firing pattern of the target neurons using extracellular recordings. After obtaining a GO seal, a single-shot hyperpolarizing pulse (0.6-0.9 nA; duration, 30 ms) was applied to rupture the neuronal membrane. To determine whether each recorded RVLM neuron was a bulbospinal one, the existence of antidromic action potentials (APs) in a RVLM neuron (Figure 1b ) was examined by electrical stimulation of the intermediolateral cell column at the Th 2 level using a tungsten electrode (30 mm tip diameter; Unique Medical, Tokyo, Japan). The RVLM neurons that had antidromic APs with electrical stimulation in the intermediolateral cell column at the Th 2 level were considered to be bulbospinal RVLM neurons. The MPs were recorded using the current-clamp technique (20 pA increments from À100-20 pA, 500 ms in duration). All of the data were recorded and analyzed using PowerLab (AD Instruments, Colorado Springs, CO, USA). The membrane resistances for the RVLM neurons were calculated from current-voltage curves. During the course of the whole-cell recordings, the neurons were labeled with Lucifer-Yellow either by spontaneous diffusion or iontophoresis. A chloride ion equilibrium potential of À89 mV was calculated using the Nernst equation and the intracellular and extracellular chloride concentrations.
Experimental protocols
Protocol (1). The bulbospinal RVLM neurons were superfused with each drug. The duration of each drug (except FAD286) superfusion ranged from 10-15 min. During superfusion with each drug, we defined depolarization as an increase of more than 2 mV in the MP and hyperpolarization as a decrease of more than 2 mV in the MP. The change in the MPs was determined 10 min after starting superfusion with each drug.
The duration of FAD286 superfusion was 5 min. The definitions of depolarization and hyperpolarization were the same as those described above. The change in the MPs was determined at the points where the minimal or maximum values were recorded after stopping superfusion with FAD286 because the effect of FAD286 was maintained even after FAD286 superfusion was stopped.
The changes in the excitatory post-synaptic potentials (EPSPs) found during drug superfusion were assessed by predefined scores. In a 2-min period, a change of more than 4 mV in the EPSP was assessed as one point and a change of more than 6 mV as two points. Summed points before drug superfusion (baseline) were compared with those during drug superfusion. If the result was less than one-half or more than twice the baseline, we defined the difference as positive. The change in the EPSPs was determined 9-10 min after starting superfusion with each drug.
Protocol (2). During MP recordings of the bulbospinal RVLM neurons, the preparations were superfused with aldosterone Protocol (3) . The MPs for the bulbospinal RVLM neurons were recorded during superfusion with a low-Ca 2 þ , high-Mg 2 þ solution that included aldosterone, eplerenone, FAD286 or benzamil. Before each drug superfusion, a low-Ca 2 þ , high-Mg 2 þ superfusion was performed for over 15 min to block synaptic transmission from other neurons to the recorded bulbospinal RVLM neuron. 27 Histology At the conclusion of each experiment, the preparations were fixed for at least 48 h at 4 1C in phosphate-buffered 10% formalin, and transverse 100-mm frozen sections were cut with a custom-made vibratome. Lucifer-Yellow-labeled RVLM neurons were photographed using a fluorescence microscope (BH-2; Olympus, Tokyo, Japan). Selected neurons were traced with a camera lucida attachment at a magnification of Â 400. 12, 19, 20 Neutral-Red staining was performed to verify the position of the neurons within the RVLM, and the precise location of the marked neurons was identified.
Statistics
The results are expressed as the means ± s.e.m. Comparisons of the MPs before and during drug superfusion were evaluated using the Student's t-test for paired observations. Statistical significance was set at Po0.05.
RESULTS
The recorded bulbospinal RVLM neurons (n ¼ 90) were classified into four types based on their firing patterns: three types that we previously reported 12 (regularly firing neurons (n ¼ 10; resting membrane potential, À41.9±0.1 mV; frequency of APs (frequency of APs), 3.7 ± 0.2 spikes per second), irregularly firing neurons (n ¼ 52; resting MP, À44.3 ± 0.9 mV # ; frequency of APs, 1.0 ± 0.2 spikes per second) ( # Po0.05 vs. regularly firing neurons), and silenttype neurons (n ¼ 16; resting MP, À49.9 ± 1.5 mV # ) ( # Po0.05 vs. regularly firing neurons)). The RVLM contained significant amounts of burst-type neurons (n ¼ 12; resting MP, À47.0±0.8 mV*; AP: 1.4 ± 0.3 spikes per second) (*Po0.01 vs. regularly firing neurons), which were newly found in this study ( Figures 2A, B and 3A, B).
In our previous report, 12 we classified bulbospinal RVLM neurons into three types: regularly firing neurons, irregularly firing neurons and silent-type neurons. Regularly firing neurons exhibited frequent APs (3.7 ± 0.2 spikes per second) with rare EPSPs. The MP trajectory of these neurons consisted of a gradual depolarizing interspike ramp, resulting in an AP and after-polarization. The EPSPs did not evoke APs. The irregularly firing neurons exhibited a lower frequency of APs (1.0±0.2 spikes per second) with numerous PSPs. Some of the EPSPs evoked APs. The silent-type neurons exhibited APs only during current-induced depolarization. In the present study, we identified a fourth type of neuron, the bulbospinal RVLM, which exhibited a firing pattern that included bursts. The recordings from these bursttype neurons exhibited a relatively irregular burst pattern (Figures 2A, B and 3A, B, D).
Of the 19 neurons that were examined (regularly firing, 1; irregularly firing, 10; silent-type, 2 and burst-type, 6), depolarization during aldosterone superfusion was observed in 14 (regularly firing, 1; irregularly firing, 6; silent-type, 2 and burst-type, 5). Regarding the membrane resistances of the bulbospinal RVLM neurons, there were no significant differences between before and during each drug superfusion (Table 1A) . Table 1A ). All of these 14 neurons depolarized within a few minutes after starting aldosterone superfusion. Ten of the 14 depolarized RVLM neurons showed increased EPSP amplitudes and frequencies (before, 11.3±3.8 points per minute; during, 32.7 ± 9.5 points per minute # ) ( # Po0.05 vs. before aldosterone superfusion) ( Figure 2B ). Three of the 19 bulbospinal RVLM neurons showed hyperpolarization during aldosterone superfusion (Table 1A) . Two out of these three hyperpolarized RVLM neurons showed increased EPSP amplitudes and frequencies (before, Presence of aldosterone, MRs and ENaCs in the RVLM N Oshima et al 4.5 ± 0.5 points per minute; during, 27.0 ± 13.0 points per minute) ( Figure 4B ). These EPSPs suggest that other neurons and astrocytes send inputs to the RVLM neurons and excite them.
To block the effects of such inputs, we superfused the preparation with a low-Ca 2 þ , high-Mg 2 þ solution. Nine out of the 14 bulbospinal RVLM neurons depolarized during superfusion of aldosterone dissolved in a low-Ca 2 þ , high-Mg 2 þ solution ( Figure 2D , Table 1B ). The results suggest that these neurons had depolarized by themselves without receiving input from other neurons.
Effect of eplerenone on bulbospinal RVLM neurons
Thirteen of the 15 bulbospinal RVLM neurons became hyperpolarized during eplerenone superfusion ( Figure 3A , Table 1A ). Among these 13 hyperpolarized RVLM neurons, six neurons showed decreased EPSP amplitudes and frequencies (before, 32.1±11.0 points per minute; during, 13.1 ± 6.0 points per minute # ) ( # Po0.05 vs. before eplerenone superfusion) ( Figure 3B) .
Eight of the 10 bulbospinal RVLM neurons became hyperpolarized during superfusion with eplerenone dissolved in a low-Ca 2 þ , highMg 2 þ solution ( Figure 3C , Table 1B ). These results strongly suggested the existence of MRs in the bulbospinal RVLM neurons. 
No change (n ¼ 0) Hyperpolarization (n ¼ 13)
No change (n ¼ 3) Before À44.7±2.7 375±184 After À44.5 ± 2.5 369 ± 177 Hyperpolarization (n ¼ 14)
Values are mean ± s.e.m. *Po0.01, # Po0.05 vs before each drug superfusion.
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In the 4 neurons that exhibited hyperpolarization during eplerenone superfusion (before, À41.6 ± 0.8 mV; during, À46.0 ± 1.5 mV # ) ( # Po0.05 vs. before eplerenone superfusion), aldosterone was added to the superfused solution to examine the MR-blocking effect of eplerenone. As a result, all four bulbospinal RVLM neurons did not show any obvious changes during superfusion with aldosterone (before, À46.0 ± 1.5 mV; during, À44.8 ± 1.8 mV # ) ( Figure 3D ). These results suggest that prior superfusion with eplerenone suppressed the effect of aldosterone on RVLM neurons.
To investigate whether eplerenone induced a reverse effect on RVLM neurons relative to aldosterone, eplerenone superfusion was applied after finishing the aldosterone superfusion. We examined the two bulbospinal RVLM neurons that showed hyperpolarization during aldosterone superfusion. In both cases, the RVLM neuron became hyperpolarized during aldosterone superfusion ( Figure 4A, left panel) , and the MPs returned to the resting level during a wash out with aCSF superfusion. After that, these neurons were depolarized during eplerenone superfusion ( Figure 4A, right panel) . Eplerenone and aldosterone thus had opposite effects.
Effect of FAD286 on bulbospinal RVLM neurons
All five bulbospinal RVLM neurons became hyperpolarized (before, À40.4±0.5 mV; after, À47.5±1.4 mV # ) ( # Po0.05 vs. before FAD286 superfusion) during and after FAD286 superfusion (Figures 5Aa, b and B, and Table 1A ). After starting the FAD286 superfusion, the RVLM neurons became hyperpolarized within 5 min, and the effect was sustained (decreased MPs) for B10-20 min after stopping FAD286 superfusion ( Figure 5B ). All five hyperpolarized RVLM neurons had decreased EPSP amplitudes and frequencies (before, 27.8 ± 8.4 points per minute; after, 3.6 ± 1.2 points per minute # ) ( # Po0.05 vs. before FAD286 superfusion) during and after FAD286 superfusion ( Figure 5B ).
All four bulbospinal RVLM neurons became hyperpolarized during and after superfusion with FAD286 dissolved in a low-Ca 2 þ , highMg 2 þ solution (before, À42.1±2.9 mV; after, À47.8±2.8 mV*) (*Po0.01 vs. before FAD286 superfusion) ( Figure 5C , Table 1B ). The effect of FAD286 was maintained for B5-10 min after completing a FAD286 superfusion. These results suggest that aldosterone is synthesized in the RVLM.
Effect of benzamil on bulbospinal RVLM neurons
Fourteen of the 18 neurons became hyperpolarized during benzamil superfusion (Figure 6a , Table 1A ). Among these 14 hyperpolarized RVLM neurons, 10 neurons showed decreased EPSP amplitudes and frequencies (before, 17.0±4.7 points per minute; during, 5.1±2.2 points per minute # ) ( # Po0.05 vs. before benzamil superfusion) (Figure 6a ). During superfusion with benzamil dissolved in a lowCa 2 þ , high-Mg 2 þ solution, all of the seven bulbospinal RVLM neurons that were tested became hyperpolarized (Figure 6b , Table 1B ). These results suggest the existence of ENaCs in the bulbospinal RVLM neurons. 
.01, # Po0.05 vs before superfusion with aldosterone dissolved in a low-Ca 2 þ , high-Mg 2 þ solution.
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In three of these seven neurons, aldosterone was added to the solution, and all three bulbospinal RVLM neurons showed no change during superfusion with aldosterone ( Figure 6b) . The results suggest that ENaCs in the RVLM neurons were responsible for aldosteroneinduced RVLM activation.
Histology
Lucifer-Yellow staining was performed after whole-cell recordings of the bulbospinal RVLM neurons had been completed (Figures 7a-c) . Ten recorded bulbospinal RVLM neurons were histologically examined, and their locations were plotted (Figure 7a ). The average long axis of the soma of the RVLM neurons (n ¼ 10: two regularly firing neurons, four irregularly firing neurons, two silent-type neurons and two burst-type neurons) measured 25.9±1.8 mm, and the number of primary dendrites was 5.0 ± 0.8. Lucifer-yellow staining showed that those neurons were all located in the RVLM.
DISCUSSION
In this study, we found that aldosterone depolarized and eplerenone (an MR blocker) hyperpolarized the bulbospinal RVLM neurons directly. Benzamil (an ENaC blocker) hyperpolarized the bulbospinal RVLM neurons directly, and aldosterone showed no effects during superfusion with benzamil dissolved in a low-Ca 2 þ , high-Mg 2 þ solution. Thus, we considered that RVLM neurons themselves have MRs and ENaCs, and ENaCs are an underlying mechanism by which aldosterone activates RVLM neurons.
Effect of aldosterone on bulbospinal neurons in the RVLM
There have been some previous studies on aldosterone in the brainstem. Zhu et al. 9 and Nakagaki et al. 10 demonstrated that microinjected corticoids into the RVLM increased blood pressure, and Nakagaki et al. 10 also reported that microinjected aldosterone increased blood pressure more in SHRSPs than Wistar rats. Furthermore, Kumar et al. 4 detected aldosterone synthetase in ventrolateral medulla oblongata neurons, which regulate blood pressure.
However, direct evidence that aldosterone activates bulbospinal RVLM neurons, which mainly control blood pressure in the brain, has not been shown. Therefore, we examined whether aldosterone directly depolarizes RVLM neurons.
In 14 of the 19 bulbospinal RVLM neurons, aldosterone induced depolarization (Figures 2a and c, Table 1A ). These results may indicate that aldosterone increases sympathetic nerve activity by exciting bulbospinal RVLM neurons.
During superfusion with aldosterone, an increase in the amplitude of EPSPs was shown in 10 of the 14 depolarized RVLM neurons (Figure 2b ). These results suggest that neurons other than the caudal ventrolateral medulla (CVLM) neurons sent excitatory inputs to the bulbospinal RVLM neurons. If the neurons that sent activated signals to the bulbospinal RVLM neurons had been CVLM neurons, the PSPs would have been inhibitory ones. Increased EPSPs amplitude was also shown in two of the three hyperpolarized RVLM neurons (Figure 4b) . The results suggest that although recorded RVLM neurons received excitatory inputs from other neurons, RVLM neurons themselves were hyperpolarized by aldosterone.
Therefore, to negate the influence of neurons sending signals to the RVLM neurons, we used a low-Ca 2 þ , high-Mg 2 þ solution. Nine of Table 1B ). As most of the bulbospinal RVLM neurons were depolarized, aldosterone may activate those neurons directly. Aldosterone has been shown to exert its effects through genomic or non-genomic action. 28, 29 Although in some previous studies aldosterone and eplerenone was infused into the intracerebroventricles, 2,3,21 whether the responses were due to genomic action was not determined. In the present study, because the depolarization of the RVLM neurons occurred within a few minutes after starting aldosterone superfusion, the effects of aldosterone on the RVLM neurons were considered to be via a non-genomic action.
In three of the 19 bulbospinal RVLM neurons, aldosterone hyperpolarized their activity (Table 1A) . Furthermore, four of the 14 bulbospinal RVLM neurons were hyperpolarized during superfusion with aldosterone dissolved in a low-Ca 2 þ , high-Mg 2 þ solution (Table 1B) . Although the mechanism is unknown, aldosterone may also suppress the activity of some of the bulbospinal RVLM neurons.
Effect of eplerenone on bulbospinal neurons in the RVLM In 13 of the 15 bulbospinal RVLM neurons, eplerenone decreased RVLM neuronal activity (Figure 3a, Table 1A ), and eight of the 10 bulbospinal RVLM neurons were hyperpolarized during superfusion with eplerenone dissolved in a low-Ca 2 þ , high-Mg 2 þ solution (Figure 3c, Table 1B ). These results suggest that eplerenone hyperpolarized the bulbospinal RVLM neurons' activity directly and that MRs exist in these neurons. In all four of the RVLM neurons that were hyperpolarized during eplerenone superfusion, the addition of aldosterone did not induce any obvious effects in the RVLM neurons (Figure 3d ). These results suggest that eplerenone administered as a pretreatment bound to the MRs and suppressed the effects of aldosterone on the RVLM neurons.
In the brain, MRs have been reported to exist in hippocampal neurons and nuclei of the anterior hypothalamus, amygdale and brainstem. 30 Gomez-Sanchez 30 showed that intracerebroventricular infusion of inhibitors of steroidogenesis prevented the increase in blood pressure in salt-sensitive rats, and Felder 31 found that activation of brain MRs increased sympathetic discharge. Westcott et al. 5 showed that central blockade of aldosterone production and MRs prevented cardiac remodeling and dysfunction after myocardial infarction. However, the existence of MRs in the bulbospinal RVLM neurons remains undetermined. In this study, because the bulbospinal RVLM neurons depolarized or hyperpolarized during superfusion with aldosterone or eplerenone dissolved in a low-Ca 2 þ , high-Mg 2 þ solution, we concluded that the RVLM neurons have MRs; moreover, MRs are responsible for aldosterone-induced RVLM depolarization.
In six of the 13 hyperpolarized RVLM neurons, an obvious decrease in EPSP amplitudes was shown during eplerenone superfusion (Figure 3b ). The activity of the neurons (except CVLM neurons) that sent signals to the RVLM neurons was probably suppressed during eplerenone superfusion, or the CVLM neurons that sent signals to the bulbospinal RVLM neurons were activated. Presence of aldosterone, MRs and ENaCs in the RVLM N Oshima et al There were three cases in which the RVLM neurons were hyperpolarized during aldosterone superfusion (Table 1A) , and we examined the effect of eplerenone on these neurons. In two cases, the bulbospinal RVLM neurons were hyperpolarized during aldosterone superfusion and depolarized during eplerenone superfusion (Figure 4a) . Interestingly, eplerenone depolarized these neurons. Although the mechanism by which aldosterone suppressed the RVLM neurons is unknown, these results suggest that relative to aldosterone, eplerenone has the opposite effect on RVLM neurons.
Effect of FAD286 on bulbospinal neurons in the RVLM
The observation that eplerenone hyperpolarizes RVLM neurons suggests that some steroids are capable of stimulating MRs in RVLM neurons. In addition to aldosterone, glucocorticoids are also known to bind to MRs and activate them. 32, 33 Thus, to evaluate endogenously produced aldosterone, we performed an FAD286 superfusion. As a result, all five RVLM neurons became hyperpolarized (Figures 5Aa, b and B Table 1A ), suggesting the existence of aldosterone in the brainstem, including the RVLM region. The duration needed for recovery of the MPs after cessation of the FAD286 superfusion was longer than 20 min (Figure 5b ). These results suggest that some time is required to synthesize aldosterone. Furthermore, our finding that FAD286 dissolved in a low-Ca 2 þ , high-Mg 2 þ solution caused hyperpolarized RVLM neurons ( Figure 5c , Table 1B ), suggests that aldosterone exists and is synthesized in the RVLM. In a previous study, Connell et al. 1 showed that the central nervous system can produce aldosterone. Furthermore, using FAD286, Gomez-Sanchez et al. 2 and Hung et al. 6, 7 proved that aldosterone is synthesized in the brain. Kumar et al. 4 demonstrated the presence of aldosterone-related mRNA species in the RVLM. However, to our knowledge, no previous reports have shown any evidence that endogenous aldosterone has effects in the RVLM. Therefore, our study may be the first to suggest that endogenous aldosterone activates bulbospinal RVLM neurons.
Effect of ENaC on bulbospinal neurons in the RVLM
In the brain, ENaC has been reported to exist in the supraoptic nucleus, magnocellular paraventricular nucleus, hippocampus, choroid plexus and ependyma. 22, 34, 35 Wang et al. 36 showed the presence of ENaC in the choroid plexus and the ependyma of the anteroventral third ventricle, and reported that intracerebroventricular infusion of aldosterone increased blood pressure and intracerebroventricular infusion of benzamil blocked this increase. To our knowledge, there are no reports that have indicated the existence of ENaCs in bulbospinal RVLM neurons.
In the present study, we showed the effect of benzamil in the bulbospinal RVLM neurons. In 14 of the 18 neurons, the bulbospinal RVLM neurons were hyperpolarized during benzamil superfusion (Figure 6a , Table 1A ). In 3 of the 14 hyperpolarized neurons, an obvious decrease in EPSP amplitudes was shown during benzamil superfusion (Figure 6a) . The results suggest that activation by some of the neurons (except for the CVLM neurons), which were sending signals to the RVLM neurons, was suppressed during benzamil superfusion. To block the signals from other neurons that synapse with RVLM neurons, the brainstem-spinal preparations were superfused with a low-Ca 2 þ , high-Mg 2 þ solution. During superfusion with benzamil dissolved in a low-Ca 2 þ , high-Mg 2 þ solution, all of the 7 bulbospinal RVLM neurons were hyperpolarized (Figure 6b and Table 1B ). Aldosterone, added to a benzamil superfusion dissolved in a low-Ca 2 þ , high-Mg 2 þ solution, did not depolarize the RVLM neurons (Figure 6b ). These results strongly suggest that ENaCs are responsible for aldosterone-induced RVLM depolarization.
The mechanisms by which ENaC inhibition leads to suppressed RVLM neuron activity are unknown. Previous reports have shown the effect of benzamil. Benzamil injected into brain ventricles improved hypertension by releasing vasopresin 37 or suppressing brain reninangiotensin system (RAS) mRNAs 38 by blocking brain sodium channels in salt-sensitive hypertension rats. Moreover, benzamil reportedly activates endothelial nitric oxide synthase (eNOS) and produces nitric oxide (NO) in rat mesenteric arteries by blocking ENaCs. 26 In this study, these mechanisms may have influenced the MPs of the RVLM neurons in addition to blocking the inward sodium ion current.
The mechanisms underlying the sympathetic hyperactivity caused by aldosterone have not yet been established. According to previous reports, 36, 39 aldosterone in the brain causes ouabain production and oxidative stress, which in turn stimulates sympathetic outflow in the central nervous system. Our results suggest that aldosterone depolarized bulbospinal RVLM neurons directly and that ENaCs are involved in this action. The stimulation of RVLM neurons by aldosterone through ENaCs may be a pathway of sympathetic hyperactivity, in addition to the ''ouabain or oxidative stress pathway'' caused by aldosterone.
Bulbospinal RVLM neurons can be classified into four types based on their firing patterns In this study, we found burst-type neurons, in addition to the three other types of neurons, which we previously reported. 12 As these neurons had antidromic APs evoked by electrical stimulation in the intermediolateral cell column at the Th 2 level, they participate in sympathetic nerve discharge. They also depolarized during aldosterone superfusion. The resting MPs of these burst-type neurons were more negative than those of regularly firing neurons.
Toney et al. 40 reported the existence of burst-firing RVLM neurons that are barosensitive and respiratory rhythmic, using an extracellular recording method in vivo. In our study, the burst-type neurons in the RVLM may have been modulated by the respiratory network, but their firing patterns differed from those of the respiratory neurons 14 recorded using whole-cell recordings from a preparation similar to ours.
In summary, aldosterone depolarized and eplerenone hyperpolarized the bulbospinal RVLM neurons directly, suggesting that MRs are involved in the depolarization of RVLM neurons. The result that FAD286 hyperpolarized the bulbospinal RVLM neurons directly suggests that aldosterone is synthesized in the RVLM. We demonstrated that benzamil hyperpolarized the bulbospinal RVLM neurons directly, and aldosterone had no effects during superfusion with benzamil dissolved in a low-Ca 2 þ , high-Mg 2 þ solution. These data suggest that ENaCs are involved in aldosterone-induced depolarization of RVLM neurons.
Synthesized aldosterone in the RVLM may contribute to increased sympathetic nerve activity by activating the bulbospinal RVLM neurons through ENaCs, which leads to increased blood pressure. In the hypertensive state, increased aldosterone production may occur in the RVLM.
